Reduced susceptibility of Proteus mirabilis to triclosan

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 991-994

  Stickler, David J ^a   Jones, Gwennan L ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BIOCIDE; TRICLOSAN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BALLOON CATHETER; BIOFILM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; URINARY TRACT;

ANTI-INFECTIVE AGENTS, LOCAL; BIOFILMS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, ANATOMIC; MUTATION; PROTEUS MIRABILIS; TRICLOSAN; URINARY BLADDER; URINARY CATHETERIZATION;

EID: 40549137098     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01094-07     Document Type: Article

References (29)

1. Aiello, A. E., E. L. Larsen, and S. B. Levy. 2007. Consumer antibacterial soaps: effective or just risky? Clin. Infect. Dis. 45(Suppl 2):S137-S147.
2. Aiello, A. E., B. Marshall, S. B. Levy, P. Della-Latta, S. X. Lin, and E. Larsen. 2005. Antibacterial cleaning products and drug resistance. Emerg. Infect. Dis. 11:1565-1570.
3. Brown, D. F., and L. Brown. 1991. Evaluation of the E-test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother. 27:185-190.
4. Cookson, B. D., H. Farrelly, P. Stapleton, R. P. J. Garvey, and M. R. Price. 1991. Transferable resistance to triclosan in MRSA. Lancet 337:1548-1549.
5. Expert Review Panel of Colgate Total. 2000. Laboratory and clinical evidence documenting the microbiologic safety of Colgate Total. Biol. Ther. Dent. 16:17-20.
6. Fine, D. H., D. Furgang, Y. Bonta, W. DeVisio, A. R. Volpe, H. Reynolds, J. J. Zambon, and R. G. Dunford. 1998. Efficacy of triclosan/NaF dentrifice in the control of plaque and gingivitis and concurrent oral microflora monitoring. Am. J. Dent. 11:259-270.
7. Griffith, D. P., D. M. Musher, and C. Itin. 1976. Urease. The primary cause of infection-induced urinary stones. Investig. Urol. 13:346-350.
8. Jones, G. L., C. T. Muller, M. O'Reilly, and D. J. Stickler. 2006. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J. Antimicrob. Chemother. 57:266-272.
9. Jones, G. L., A. D. Russell, Z. Caliskan, and D. J. Stickler. 2005. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. Eur. Urol. 48:838-845.
10. Karatzas, K. A. G., M. A. Webber, F. Jorgensen, M. J. Woodward, L. J. V. Piddock, and T. J. Humphrey. 2007. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J. Antimicrob. Chemother. 60:947-955.
11. Kohler-Ockmore, J., and R. C. L. Feneley. 1996. Long-term catheterization of the bladder: prevalence and morbidity. Br. J. Urol. 77:347-351.
12. Kunin, C. M. 1989. Blockage of urinary catheters: role of microorganisms and constituents of the urine on formation of encrustations. J. Clin. Epidemiol. 42:835-842.
13. Kunin, C. M. 1997. Urinary tract infections: detection, prevention and management, 5th ed. Williams and Wilkins, Baltimore, MD.
14. Ledder, R. G., P. Gilbert, C. Willis, and A. J. McBain. 2006. Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates. J. Appl. Microbiol. 100:1132-1140.
15. Levy, S. B. 2002. Factors impacting on the problem of antibiotic resistance. J. Antimicrob. Chemother. 49:25-30.
16. Maillard, J.-Y. 2007. Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern? J. Hosp. Infect. 62(Suppl. 2):60-72.
17. McBain, A. J., R. G. Bartolo, C. E. Catrenich, D. Charbonneau, R. G. Ledder, B. B. Price, and P. Gilbert. 2003. Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility. Appl. Environ. Microbiol. 69:5433-5442.
18. McMurry, L. M., M. Oethinger, and S. B. Levy. 1998. Triclosan targets lipid synthesis. Nature 394:531-532.
19. Mobley, H. L. T., and J. W. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25:2216-2217.
20. Morris, N. S., D. J. Stickler, and R. J. McLean. 1999. The development of bacterial biofilms on indwelling urethral catheters. World J. Urol. 17:345-350.
21. Morris, N. S., D. J. Stickler, and C. Winters. 1997. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br. J. Urol. 80:58-63.
22. Russell, A. D. 2004. Whither triclosan? J. Antimicrob. Chemother. 53:693-695.
23. Schweizer, H. P. 2001. Triclosan: a widely used biocide and its links to antibiotics. FEMS Microbiol. Lett. 202:1-7.
24. Sreenivasan, P., and A. Gaffar. 2002. Antiplaque biocides and bacterial resistance: a review. J. Clin. Periodontol. 29:965-974.
25. Stickler, D. J., G. L. Jones, and A. D. Russell. 2003. Control of encrustation and blockage of Foley catheters. Lancet 361:1435-1437.
26. Stickler, D. J., N. S. Morris, and C. Winters. 1999. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol. 310:494-501.
27. Stickler, D. J., and J. Zimakoff. 1994. Complications of urinary tract infections associated with devices used for long-term bladder management. J. Hosp. Infect. 28:177-194.
28. Suller, M. T. E., and A. D. Russell. 2000. Triclosan and antibiotic resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 46:11-18.
29. Weber, D. J., and W. A. Rutala. 2006. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infect. Control Hosp. Epidemiol. 27:1107-1119.